News & Media

InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management

Posted on Nov 11, 2013

DOWNLOAD PDF – PISCATAWAY, N.J., Nov. 11, 2013 — InnoPharma, Inc. today announced the appointment of Vish Shetty to the role of vice president, business development & alliance management. Mr. Shetty has over 10 years of extensive experience in market research, portfolio management, marketing, product launches, business development and strategic planning with pharmaceutical companies. (more…)

InnoPharma Inc. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States

Posted on Aug 15, 2013

DOWNLOAD PDF – PISCATAWAY, N.J., Aug. 15, 2013 — InnoPharma, Inc. today announced the launch of acamprosate calcium, 333 mg delayed-release tablets (generic equivalent of Campral®). InnoPharma developed the generic formulation of acamprosate delayed-release tablets and entered into an agreement with Glenmark Pharmaceuticals, Inc. pursuant to which Glenmark will sell, market and distribute acamprosate in the United States. (more…)

InnoPharma Inc. Appoints Deborah DuFresne as Vice President, Strategic Portfolio Selection & Management

Posted on Aug 5, 2013

DOWNLOAD PDF – PISCATAWAY, N.J., Aug. 5, 2013 — InnoPharma, Inc. today announced the appointment of Deborah DuFresne to the role of Vice President, Strategic Portfolio Selection & Management. Ms. DuFresne will be responsible for leading InnoPharma’s product selection process and the management of its portfolio. Ms. DuFresne has over 10 years of extensive experience in portfolio management, marketing, product launches, business development and strategic planning with pharmaceutical companies. (more…)

InnoPharma Inc. Announces Launch of Cosyntropin Injection, 0.25mg/vial in the United States

Posted on Apr 8, 2013

DOWNLOAD PDF – PISCATAWAY, N.J., April 8, 2013 — InnoPharma, Inc. today announced the commercial launch of cosyntropin injection, 0.25mg/vial (generic equivalent of Cortrosyn®) in single-use vials. InnoPharma developed the generic formulation of cosyntropin injection. (more…)

InnoPharma Inc. Announces Launch of Generic Cidofovir Injection in the United States

Posted on Mar 8, 2013

DOWNLOAD PDF – PISCATAWAY, N.J., March 8, 2013 — InnoPharma, Inc. today announced the launch of cidofovir injection (generic equivalent of Vistide®) in 5mL single-use vials. InnoPharma developed the generic formulation of cidofovir, which will be marketed in the United States by Mylan, Inc. (NASDAQ: MYL). (more…)